CLINICAL_TRIALS
trial_result
· 2022-02-01
Clinical Trial Update: An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis [Phase 3]
Summary
An extension study (Phase 3) in participants with moderate to severe rheumatoid arthritis has completed enrollment and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Eli Lilly and Company | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2022-02-01